SCHEMBL5522031

SCHEMBL5522031

Cc1ccc(-c2cc(C(=O)NC(C)(C)C)nn2-c2cccnc2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.52
CNR2 P34972 5/20 0.52
CYP3A4 P08684 1/20 0.41
CYP2A6 P11509 1/20 0.41
MARS1 P56192 3/20 0.41
RIPK1 Q13546 1/20 0.38
SMPD1 P17405 1/20 0.38
SLC16A3 O15427 1/20 0.37
SLC16A1 P53985 1/20 0.37
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
ANO1 Q5XXA6 1/20 0.36
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518588 0.90 CNR1 (0.66) CNR1CNR2CYP3A4CYP2A6MARS1
SCHEMBL5522084 0.90 CNR1 (0.52) CNR1CNR2MARS1RIPK1SLC16A3
SCHEMBL5522045 0.89 CNR1 (0.55) CNR1CNR2CYP3A4CYP2A6MARS1
SCHEMBL5529097 0.89 CNR1 (0.51) CNR1CNR2MARS1RIPK1SLC16A3
SCHEMBL5529104 0.89 CNR1 (0.51) CNR1CNR2MARS1SMPD1SLC16A3
SCHEMBL5526269 0.89 CNR1 (0.51) CNR1CNR2MARS1
SCHEMBL5519765 0.89 CNR1 (0.53) CNR1CNR2CYP2A6MARS1RIPK1
SCHEMBL5528493 0.88 CNR1 (0.52) CNR1CNR2MARS1RIPK1SLC16A3
SCHEMBL5522538 0.87 CNR1 (0.49) CNR1CNR2MARS1SLC16A3SLC16A1
SCHEMBL5525578 0.87 CNR1 (0.49) CNR1CNR2MARS1RIPK1SLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 CNR1 76/4885CNR2 43/4885CYP3A4 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.